Federated Hermes
DERM icon

Federated Hermes’s Journey Medical DERM Stock Holding History

Federated Hermes’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-144
Closed -$675 – 2075
2026
Q1 		$675 Hold
144
– – ﹤0.01% 2022
2025
Q4 		$1.11K Buy
+144
New +$1.13K ﹤0.01% 2012
2024
Q4 		– Sell
-853
Closed -$4.82K – 2103
2024
Q3 		$4.82K Sell
853
-476
-36% -$2.45K ﹤0.01% 1861
2024
Q2 		$7.5K Hold
1,329
– – ﹤0.01% 1804
2024
Q1 		$4.89K Buy
1,329
+496
+60% +$2.16K ﹤0.01% 1841
2023
Q4 		$4.8K Buy
+833
New +$3.71K ﹤0.01% 1860

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Federated Hermes's DERM Position: Q2 2026 in Review

Federated Hermes sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 144 shares — an estimated $675 sold.

Federated Hermes first reported a position in DERM in Q4 2023 and held it in 6 quarters. The position peaked at $7.5K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Federated Hermes reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 144 Journey Medical shares in Q2 2026, an estimated $675.
  • Federated Hermes first reported a position in Journey Medical in Q4 2023 and held it in 6 quarters.
  • Federated Hermes's Journey Medical position peaked at $7.5K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.